LOWE Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for LOWE with the United States Patent and Trademark Office. The USPTO has given the LOWE trademark a serial number of 98380925. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 25, 2025. This trademark is owned by Recursion Pharmaceuticals, Inc.. The LOWE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding
General Information
| Serial Number | 98380925 |
| Word Mark | LOWE |
| Filing Date | Monday, January 29, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, March 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 1, 2024 |
Trademark Statements
| Goods and Services | Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Recursion Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84101 |
| Party Name | Recursion Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84101 |
Trademark Events
| Event Date | Event Description |
| Monday, January 29, 2024 | NEW APPLICATION ENTERED |
| Friday, August 23, 2024 | ASSIGNED TO EXAMINER |
| Friday, August 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 1, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, October 7, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, October 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, February 10, 2025 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, March 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
